Top Markets
#1 Akedo Akedo +12.06%
#2 MarsCoin MarsCoin +11.66%
#3 EXOD EXOD +9.04%
#4 Solstice Solstice +8.28%
#5 ETHGas ETHGas +7.54%
#6 龙虾 (Lobster) 龙虾 (Lobster) +6.80%
#7 Seeker Seeker +5.97%
#8 DexNet DexNet +5.76%
#9 peaq peaq +5.53%
#10 Official Trump Official Trump +5.49%
Coin of the day
Akedo Akedo
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Rangering i aksjer #6692
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
Aksjekurs
$30.90
Sist synkronisert: 2026-08-27
Markedsverdi
$1.90B
Endring (1 dag)
1.68%
Endring (1 år)
859.63%
Land
US
Handel Damora Therapeutics, Inc. (DMRA)

Kategori

Healthcare
Utbytteavkastning for Damora Therapeutics, Inc. (DMRA)
Damora Therapeutics, Inc. (aksjesymbol: DMRA) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Damora Therapeutics, Inc. (DMRA) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH